focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Apr 2011 11:47

RNS Number : 3584F
Surgical Innovations Group PLC
21 April 2011
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

 

 

 Surgical Innovations Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Transfer into Nominees

X

3. Full name of person(s) subject to thenotification obligation: iii

Rensburg Sheppards Investment Management Limited

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

19th April 2011

6. Date on which issuer notified:

20th April 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary Shares

GB0004016704

 

11,493,000

 

11,493,000

 

12,493,000

 

3.19%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,493,000

3.19%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Client holdings registered in the name of Nominee companies 100% owned by Rensburg Sheppards Investment Management Limited.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Phil Beardwell Chartered FCSI

Senior Compliance Manager

 

15. Contact telephone number:

020 7597 1356

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Rensburg Sheppards Investment Management Limited

Contact address

(registered office for legal entities)

 

Quayside House

Canal Wharf

Leeds LS11 5PU

Phone number & email

 

0113 236 4171

mike.rigby@rsim.co.uk

Other useful information

(at least legal representative for legal persons)

 

Mike Rigby

(Head of Compliance)

B: Identity of the notifier, if applicable

Full name

 

Philip Martin Beardwell

Contact address

 

2 Gresham Street

London

EC2V 7QN

Phone number & email

 

020 7597 1356

phil.beardwell@rsim.co.uk

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Senior Compliance Manager

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUASRRAVASUAR
Date   Source Headline
18th Oct 20137:00 amRNSCFO to present at London Investor Show
17th Oct 20137:00 amRNSInternational Clinical Advisory Board Appointment
4th Oct 20137:00 amRNSAppointment to the Clinical Advisory Board
10th Sep 20137:00 amRNSInterim Results
16th Aug 20137:00 amRNSTrading update
19th Jun 20134:06 pmRNSResult of AGM
19th Jun 20132:00 pmRNSAGM Statement
10th Jun 20137:00 amRNSPilot hip arthroscopy test
3rd Jun 20137:00 amRNSAppointment to the Clinical Advisory Board
29th May 20137:00 amRNSNew US dealer
22nd May 20137:00 amRNSDevelopment agreement for Industrial application
8th May 20137:00 amRNSSnr Appointment of President US Sales & Operations
17th Apr 20137:00 amRNSAppointment to the Clinical Advisory Board
9th Apr 20137:00 amRNSPreliminary Results
18th Mar 20137:00 amRNSChange of Adviser
11th Mar 20137:00 amRNSUS appointment to ICAB
19th Feb 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSPretzelFlex 3mm FDA approval
22nd Jan 20137:00 amRNSSecond order of 5mm PretzelFlex® shipped
17th Jan 20137:00 amRNSSI to benefit from £5.05m RGF Grant
10th Jan 20137:00 amRNSDirectors shareholding
18th Dec 20129:24 amRNSDirectors' dealings and issue of equity
18th Dec 20127:00 amRNSAppointments to the Clinical Advisory Board
29th Oct 20127:00 amRNSFirst PretzelFlex® orders shipped to CareFusion
11th Oct 20127:00 amRNSSuccessful exhibition at ISHA in the US
18th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSNotice of Results
30th Aug 20122:14 pmRNSHolding(s) in Company
26th Jun 20127:00 amRNSGrant of options
19th Jun 20123:33 pmRNSResult of AGM
19th Jun 20127:00 amRNSAGM Statement
18th Jun 20127:00 amRNSOEM distribution agreement with CareFusion
31st May 20127:00 amRNSUK distribution agreement
25th May 201211:58 amRNSDirectorate Change
22nd May 20127:00 amRNSPublication of Annual Report and Notice of AGM
1st May 20127:00 amRNSInvestor site visit
24th Apr 20127:00 amRNSFinal Results
20th Apr 20127:00 amRNSNotice of Results
15th Mar 20127:00 amRNSFDA 510(k) approval for reusable PretzelFlexT
23rd Feb 20124:54 pmRNSHolding(s) in Company
17th Feb 20124:36 pmRNSDirector/PDMR Shareholding
14th Feb 20125:49 pmRNSIssue of Equity
1st Feb 20127:00 amRNSRe: US contract and FDA approval
23rd Jan 20127:01 amRNSTrading Statement
2nd Dec 20117:00 amRNSInvestor Site Visit
3rd Nov 20117:00 amRNSIssue of Equity
1st Nov 20117:00 amRNSConfirmation of successful RGF bid
21st Sep 20114:49 pmRNSIssue of Equity
14th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20115:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.